Low peripheral blood derived neutrophil-to-lymphocyte ratio (dNLR) is associated with increased tumor T-cell infiltration and favorable outcomes to first-line pembrolizumab in non-small cell lung cancer

BACKGROUND: An elevated peripheral blood derived neutrophil-to-lymphocyte ratio (dNLR) is a negative prognostic marker for patients with non-small cell lung cancer (NSCLC) receiving chemotherapy and immune checkpoint inhibitors. Whether dNLR is also associated with clinical outcomes to first-line pe...

Descripción completa

Detalles Bibliográficos
Autores principales: Alessi, Joao V, Ricciuti, Biagio, Alden, Stephanie L, Bertram, Arrien A, Lin, Jessica J, Sakhi, Mustafa, Nishino, Mizuki, Vaz, Victor R, Lindsay, James, Turner, Madison M, Pfaff, Kathleen, Sharma, Bijaya, Felt, Kristen D, Rodig, Scott J., Gainor, Justin F., Awad, Mark M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Immunotherapy Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627393/
https://www.ncbi.nlm.nih.gov/pubmed/34824161
http://dx.doi.org/10.1136/jitc-2021-003536

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627393/
https://www.ncbi.nlm.nih.gov/pubmed/34824161
http://dx.doi.org/10.1136/jitc-2021-003536

Ejemplares similares